Insider Transactions Reported by 11 Insiders of Silexion Therapeutics Corp

Symbol
SLXN, SLXNW on Nasdaq
Location
Ramat Gan, Israel

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Silexion Therapeutics Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ilan Levin Director, 10%+ Owner $1,830,723 07 Aug 2025
Ilan Hadar Chairman and CEO, Director $162,081 20 Feb 2026
Mitchell Shirvan CSO and CDO $124,891 20 Feb 2026
Mirit Horenshtein Hadar CFO and Secretary $122,356 20 Feb 2026
Avner Lushi Director $88,044 20 Feb 2026
Shlomo Noy Director $88,044 20 Feb 2026
Ruth Alon Director $51,027 20 Feb 2026
Dror Yosef Abramov Director $50,910 20 Feb 2026
Amnon Peled Director $41,823 20 Feb 2026
Wildcat Capital Management, LLC 10%+ Owner 15 Aug 2024
Ilan Shiloah Director 15 Aug 2024

Recent Insider Transactions by Companies or Individuals for Silexion Therapeutics Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.